HOME › DRUGS › AUTOLOGOUS HUMAN CHONDROCYTES IN VITRO EXPANDED
ACTIVE SUBSTANCE / INN

AUTOLOGOUS HUMAN CHONDROCYTES IN VITRO EXPANDED

Brand name(s): Artobend
EMA LISTED
APPLICATION WITHDRAWN
Fractures, Cartilage
ACTIVE SUBSTANCE
Autologous Human Chondrocytes In Vitro Expanded
REGULATORS
EMA
SPONSORS / MAH
TETEC Tissue Engineering Technologies AG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ArtobendTETEC Tissue Engineering Technologies AGApplication withdrawnFractures, Cartilage

FULL INTELLIGENCE ON AUTOLOGOUS HUMAN CHONDROCYTES IN VITRO EXPANDED

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →